Showing results (1731-1740 of 1,804) with videos related to

Sort By:
Pageof 181
Diabetes Care|June 6, 1998
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) StudyT Valle, J Tuomilehto, R N Bergman, et al.
Prostate Cancer and Prostatic Diseases|May 4, 2016
Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic riskA E Ross, R B Den, K Yousefi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2020
T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate CancerAleksandar Z Obradovic, Matthew C Dallos, Marianna L Zahurak, et al.
Future Oncology (London, England)|November 11, 2025
Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP)Alicia K Morgans, Alex Chehrazi-Raffle, Tamim Niazi, et al.
Cancer|March 25, 2022
Association of B7-H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancerAdrianna A Mendes, Jiayun Lu, Harsimar B Kaur, et al.
Science (New York, N.Y.)|January 30, 2025
Scratching promotes allergic inflammation and host defense via neurogenic mast cell activationAndrew W Liu, Youran R Zhang, Chien-Sin Chen, et al.
Human Molecular Genetics|April 1, 1997
Linkage and physical mapping of X-linked lissencephaly/SBH (XLIS): a gene causing neuronal migration defects in human brainM E Ross, K M Allen, A K Srivastava, et al.
The Lancet. Oncology|October 17, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysisShuang G Zhao, S Laura Chang, Daniel E Spratt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2023
Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen-Targeted <sup>18</sup>F-DCFPyL PET/CTFelicia Wang, Chen Liu, Igor Vidal, et al.
Journal of the National Cancer Institute|October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic TargetShuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.
Pageof 181